Comparison

Semaglutide vs Tirzepatide Guide

Semaglutide and Tirzepatide are commonly compared in weight loss, appetite control, and metabolic-health communities.

Main difference

Semaglutide primarily targets GLP-1 receptors, while Tirzepatide targets both GLP-1 and GIP receptors. This is why Tirzepatide is often described as a dual agonist.

How they are commonly discussed

Both are commonly discussed for appetite control, weight loss, reduced food noise, and metabolic health. Tirzepatide is often discussed as having broader receptor activity.

Side effects people compare

Both are commonly associated with nausea, constipation, diarrhea, reflux, appetite suppression, and stomach discomfort. Individual responses vary.

FAQ

Which one is stronger?

Online users often discuss Tirzepatide as stronger for appetite and weight loss, but individual responses vary and prescription decisions should be made with a clinician.

Can this site compare dosing?

BACToBasics can explain reconstitution math, but it does not provide medical dosing advice.

BACToBasics provides educational information and math tools only. This content is not medical advice, dosing advice, or a recommendation to use any peptide, medication, stack, or protocol.